RenovoRx RNXT Q4 2024 Annual earnings
Reported March 31, 2025 · Before market open
Revenue estimate$167.5K
EPS estimate-$0.13
Next report
Aug 13, 2026 (in a month)Revenue estimate$703.8K
EPS estimate-$0.08
Versus estimates
Revenue
Diluted EPS
Q1 2026-$0.08In lineQ4 2025-$0.08In lineQ3 2025-$0.08In lineQ2 2025-$0.08In lineQ1 2025-$0.08In line
Q4 2024-$0.12Beat by $0.01
Ask the moment RenovoRx reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did RenovoRx report Q4 2024 earnings?
- RenovoRx (RNXT) reported Q4 2024 earnings on March 31, 2025 before market open.
- What were RenovoRx's Q4 2024 revenue and EPS?
- RenovoRx reported revenue of $43.0K and diluted EPS of $-0.12 for Q4 2024.
- Did RenovoRx beat estimates in Q4 2024?
- Revenue missed the consensus estimate of $167.5K by $124.5K. EPS beat the consensus estimate of $-0.13 by $0.01.
- Where can I find RenovoRx's Q4 2024 SEC filings?
- You can read the 10-K periodic report (0001641172-25-001932) directly on SEC EDGAR. The filing index links above go to sec.gov.